Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Distribution

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Revenue projections:

Revenue projections for CAH
Revenue projections for CAH

CAH's revenue is projected to decrease from last year, a development that could lead investors to adopt a more cautious approach. A revenue decline can negatively affect profitability, signaling challenges for the company and making it less attractive for those seeking solid financial performance.

Financial Ratios:

currentRatio 0.906000
forwardPE 17.506458
debtToEquity 0.000000
earningsGrowth 0.194000
revenueGrowth 0.188000
grossMargins 0.036950
operatingMargins 0.012330
trailingEps 6.960000
forwardEps 11.585440

Cardinal Health, Inc.'s Forward PE is in a reasonable range, indicating the stock is priced well relative to its earnings. The stock isn't overpriced, which leaves room for future growth, making it an attractive option for investors seeking value and long-term gains.
CAH's positive earnings and revenue growth suggest that the company is expected to expand its business. This reflects a healthy financial outlook, as CAH's increasing profits and sales signal further growth in the near future.
CAH's forward EPS exceeding its trailing EPS implies that the company is projected to be more profitable this year. This suggests an improvement in financial performance, with analysts expecting CAH to generate stronger earnings compared to the previous financial year.

Price projections:

Price projections for CAH
Price projections for CAH

CAH's present price, in relation to its projections, shows no obvious risks or opportunities. This neutral outlook suggests stability, where investors might consider waiting for more decisive signals before making any significant moves.

Insider Transactions:

Insider Transactions for CAH
Insider Transactions for CAH


There were 5 transactions selling CAH stock, with prevailing market price of 196.502001953125.No sell transactions occurred in the period under review.With more buying than selling around Cardinal Health, Inc.'s current price, investors could be expressing optimism. This trend may suggest that the market expects favorable outcomes for the stock, leading to an increased demand at these levels.

Recommendation changes over time:

Recommendations trend for CAH
Recommendations trend for CAH


Analysts have been favoring CAH with a buy bias recently, signaling a promising investment opportunity. This optimistic outlook may attract more investors, positioning CAH as a desirable option for those seeking to invest their money in a stable, profitable company with strong growth potential.